Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Two out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 68 points (0.4%) at 17,048 as of Thursday, Aug. 21, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,747 issues advancing vs. 1,215 declining with 171 unchanged. The Health Services industry currently sits down 0.2% versus the S&P 500, which is up 0.3%. Top gainers within the industry include Smith & Nephew ( SNN), up 1.2%, Grifols ( GRFS), up 0.9%, Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.7% and WellPoint ( WLP), up 0.6%. On the negative front, top decliners within the industry include Cyberonics ( CYBX), down 6.5%, and ResMed ( RMD), down 0.7%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $0.59 (0.7%) to $82.48 on light volume. Thus far, 418,342 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $81.70-$82.63 after having opened the day at $81.78 as compared to the previous trading day's close of $81.89. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Stryker Corporation has a market cap of $31.0 billion and is part of the health care sector. Shares are up 9.0% year-to-date as of the close of trading on Wednesday. Currently there are 13 analysts who rate Stryker Corporation a buy, no analysts rate it a sell, and 7 rate it a hold. TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.